Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
neoantigen dna vaccine (1 trial)
allogeneic natural killer cells (1 trial)
hekt cell (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Lung Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (3 total)